Focused on life sciences and healthcare investments, the fund manager has a track record of backing innovative companies in the biotech and medical device sectors. With deep experience in early-stage funding across North America and Europe, they have successfully completed over 50 deals. Known for a hands-on approach, they emphasize strategic partnerships that drive growth and enhance exit opportunities. Their investment strategy combines rigorous analysis with a commitment to supporting transformative healthcare solutions.